Microsomal triglyceride transfer protein 493-T variant is associated with resistin levels and C-reactive protein

Clinical Biochemistry

Volumn 40, Issue 16-17, 2007, Pages 1219-1224

  Gambino, Roberto ^a   Bo, Simona ^a   Musso, Giovanni ^a   Uberti, Barbara ^a   Alemanno, Natalina ^a   Ghione, Federica ^a   Guidi, Sabrina ^a   Tiozzo, Elisa ^a   Chiusano, Valentina ^a   Gentile, Luigi ^a   Durazzo, Marilena ^a   Pagano, Gianfranco ^a   Cassader, Maurizio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

hs C reactive protein; Lipids; Microsomal triglyceride transfer protein; Polymorphism; Resistin

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; RESISTIN;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EXERCISE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ALLELES; C-REACTIVE PROTEIN; CARRIER PROTEINS; CHOLESTEROL, LDL; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; MIDDLE AGED; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RESISTIN; SEQUENCE ANALYSIS, DNA;

EID: 35248893002     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.07.005     Document Type: Article

References (38)

1. Wetterau J.R., Combs K.A., Spinner S.N., and Joiner B. Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex. J. Biol. Chem. 265 (1990) 9801-9807
2. Wetterau J.R., Lin M.C., and Jamil H. Microsomal triglyceride transfer protein. Biochim. Biophys. Acta 1345 (1997) 136-150
3. Bakillah A., and El Abbouyi A. The role of microsomal triglyceride transfer protein in lipoprotein assembly: an update. Front. Biosci. 8 (2003) d294-d305
4. Rustaeus S., Stillemark P., Linberg K., et al. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in Mca-RH7777 cells. J. Biol. Chem. 273 (1998) 5196-5203
5. Shoulders C.C., Brett D.J., Bayliss J.D., et al. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDA subunit of a microsomal triglyceride transfer protein. Hum. Mol. Genet. 2 (1993) 2109-2116
6. Ledmyr H., Karpe F., Lundhal B., et al. Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol level and body mass index. J. Lipid Res. 43 (2002) 51-58
7. Karpe F., Lundhal B., Ehrenborg E., et al. A common functional polymorhism in the promoter region of the microsomal triglyceride transfer protein gene influence plasma LDL levels. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 756-761
8. Talmud P.J., Palmen J., Miller G., and Humphries S.E. Effect of microsomal triglyceride transfer protein gene variants (-493G(T, Q95H and H297Q) on plasma lipid levels in healthy middle-aged UK men. Ann. Hum. Genet. 64 (2000) 269-276
9. Lundhal B., Leren T.P., Ose L., et al. A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP-493G/T) influences lipoprotein phenotype in familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1784-1788
10. Couture P., Otvos J.D., Cupples L.A., et al. Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoprotein in the Framingham Offspring study. Atherosclerosis 148 (2000) 337-343
11. Juo S.H., Han Z., Smith J.D., et al. Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, apoB, and triglyceride level in young African American men: results from the coronary artery risk development in young adults (CARDIA) study. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1316-1322
12. St-Pierre J., Lemieux I., Miller-felix I., et al. Visceral obesity and hyperinsulinemia modulate the impact of the microsomal triglyceride transfer protein -493G/T polymorphism on plasma lipoprotein levels in men. Atherosclerosis 160 (2002) 317-324
13. Ledmyr H., McMahon A.D., Ehrenborg E., et al. The microsomal triglyceride transfer protein gene -493T variant lowers cholesterol but increases the risk of coronary heart disease. Circulation 109 (2004) 2279-2284
14. Stejskal D., Adamovská S., Bartek J., et al. Resistin-concentrations in person with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed. Papers 147 (2003) 63-69
15. Silswal N., Singh A., Aruna B., Mukhopadhyay S., Ghosh S., and Ehtesham N.Z. Human resistin stimulates the synthesis and secretion of pro-inflammatory citokines TNF-α and IL-12 in macrophages via a NF-kB-dependent pathway. Biochem. Biophys. Res. Commun. 334 (2005) 1092-1101
16. Kawanami D., Maemura K., Takeda N., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys. Res. Commun. 314 (2004) 415-419
17. Kunnari A., Ukkola O., Päivänsalo M., and Kesäniemi Y.A. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J. Clin. Endocrinol. Metab. 91 (2006) 2755-2760
18. Bo S., Gentile L., Ciccone G., et al. The metabolic syndrome and high C-reactive protein: prevalence and difference by sex in a southern-European population-based cohort. Diabetes/Metab. Res. Rev. 21 (2005) 515-524
19. Bo S., Gambino R., Pagani A., et al. Relationship between human serum resistin, inflammatory markers and insulin resistance. Int. J. Obes. Relat. Metab. Disord. 29 (2005) 1315-1320
20. Lundhal B., Skoglund-Anderson C., Caslake M., et al. Microsomal triglyceride transfer protein-493 variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles. AJP-Endocrinol. Metabolismo (2006) E739-E745
21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 (2003) S5-S20
22. National Institute of Health. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
23. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
24. Saltin B., and Grimby G. Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same ages. Circulation 38 (1968) 1104-1115
25. Lunddhal B., Hamsten A., and Karpe F. Postprandial plasma apoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 289-293
26. Philips C., Mullan K., Owens D., et al. Microsomal triglyceride transfer protein polymorphisms and lipoprotein levels in type 2 diabetes. Q. J. Med. 97 (2004) 211-218
27. Karpe F., Lundhal B., Ehrenborg E., et al. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 756-761
28. Patel L., Buckels A.C., Kinghorn I.J., et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun. 300 (2003) 472-476
29. Steppan C.M., and Lazar M.A. The current biology of resistin. J. Int. Med. 255 (2004) 439-447
30. Lu S.C., Shieh W.Y., Chen C.Y., et al. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett. 530 (2002) 158-162
31. Kaser S., Kaser A., Sandhofer A., et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 309 (2003) 286-290
32. Stejskal D., Adamovska S., Bartek J., et al. Resistin: concentration in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed. Pap. Med. Fac. Univ. Palcky Plpmouc Czech Republ. 147 (2003) 63-69
33. Muredach P.R., Lehrke M., Wolfe M.L., et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
34. Shetty G.K., Economides P.A., Horton E., et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27 (2004) 2450-2457
35. Al-Daghry N., Chetty R., McTernan P.G., et al. Serum resistin is associated with c-reactive protein and ldl cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc. Diabetol. 4 (2005) 10
36. Verma S., Li S.H., Wang C.H., et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 (2003) 736-740
37. Reilly M.P., Lehrke M., Wolfe M.L., et al. Resistin is an inflammatory markers of atherosclerosis in humans. Circulation 111 (2005) 932-939
38. Chen S.P.L., Tan K.C.B., and Lam K.S.L. Effect of the microsomal triglyceride transfer protein -493 polymorhism and type 2 diabetes mellitus on LDL subfractions. Atherosclerosis 167 (2003) 287-292